The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dreyer David C since year 2005.
The trader's CIK number is 1203607.
At the time of this reporting, Dreyer David C is the SVP / Chief Financial Officer of Biolase Technology Inc .
(stock ticker symbol BLTI).
See this page for all insider trading activities at Biolase Technology Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-07-01||BIOL||Biolase Technology Inc||Option Ex||70,000||.00||0|
|2015-11-09||BIOL||Biolase Technology Inc||Buy||33,000||.77||25,410|
|2015-09-24||BIOL||Biolase Technology Inc||Buy||5,000||1.20||6,000|
|2015-09-22||BIOL||Biolase Technology Inc||Buy||5,000||1.37||6,850|
|2015-09-17||BIOL||Biolase Technology Inc||Buy||10,000||1.45||14,500|
|2015-06-04||INFU||Healthcare Acquisition Partners Corp.||Sale||10,000||3.15||31,500|
|2015-05-29||INFU||Healthcare Acquisition Partners Corp.||Option Ex||25,000||1.52||38,000|
|2015-03-25||DPLO||Diplomat Pharmacy, Inc.||Buy||1,034||29.00||29,986|
|2014-04-05||INFU||Healthcare Acquisition Partners Corp.||Option Ex||100,000||2.25||225,000|
|2014-03-18||PSTX||Patient Safety Technologies, Inc||Option Ex||416,666||.75||312,499|
|2011-03-30||PSTX.OB||Patient Safety Technologies, Inc||Buy||100,000||.75||75,000|
|2010-12-16||PSTX.OB||Patient Safety Technologies, Inc||Buy||105,000||.78||81,375|
|2009-04-12||AHS||Amn Healthcare Services Inc||Option Ex||12,221||6.41||78,336|
|2007-11-05||AHS||Amn Healthcare Services Inc||Sale||350||18.70||6,545|
|2007-05-12||AHS||Amn Healthcare Services Inc||Option Ex||6,018||22.62||136,127|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dreyer David C (SVP / Chief Financial Officer of Biolase Technology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.